The Role of MicroRNAs in Regulatory T Cells and in the Immune Response

키워드

참고문헌 (214)

1. Gershon RK, "Infectious immunological tolerance", Immunology, 21, pp.903~914 (1971)
2. Gershon RK, "Suppressor T cells", J Immunol, 108, pp.586~590 (1972)
3. Ha TY, "Role of the thymus in tolerance. X. “Suppressor” activity of antigen-stimulated rat thymocytes transferred to normal recipients", J Immunol, 110, pp.1290~1299 (1973)
4. Ha TY, "The thymic suppressor cell. I. Separation of subpopulations with suppressor activity", J Exp Med, 139, pp.13~23 (1974)
5. Ha TY, "The thymic suppre-sor cell. II. Metabolic requirements of suppressor activity", Immunol Commun, 3, pp.351~359 (1974)
6. Mudd PA, "Regulatory T cells and systemic lupus erythematosus", Scand J Immunol, 64, pp.211~218 (2006)
7. Waksman BH, "Tolerance, the thymus, and suppressor T cells", Clin Exp Immunol, 28, pp.363~374 (1977)
8. Sakaguchi S, "Regulatory T cells and immune tolerance", Cell, 133, pp.775~787 (2008)
9. Sakaguchi S, "Naturally arising CD4＋ regulatory t cells for immunologic self-tolerance and negative control of immune responses", Annu Rev Immunol, 22, pp.531~562 (2004)
10. Ziegler SF, "FOXP3: Of Mice and Men", Ann Rev Immunol, 24, pp.209~226 (2006)
11. Qin FX, "Dynamic behavior and function of Foxp3＋ regulatory T cells in tumor bearing host", Cell Mol Immunol, 6, pp.3~13 (2009)
12. Huehn J, "Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage", Nat Rev Immunol, 9, pp.83~89 (2009)
13. 하대유, "Regulatory T Cell Therapy for Autoimmune Disease", Immune Network, 8(4), pp.107~123 (2008), 대한면역학회
14. Ha TY, "The role of suppressor T cells in bacterial infections", KAST Rev Modern Sci & Technol, 4, pp.105~120 (2008)
15. Shevach EM, "Mechanisms of foxp3＋ T regulatory cellmediated suppression", Immunity, 30, pp.636~645 (2009)
16. Sakaguchi S, "FOXP3＋ regulatory T cells in the human immune system", Nat Rev Immunol, 10, pp.490~500 (2010)
17. Ha TY, "The role of suppressor T cells in mycobacterial Infection", Korean Lepr Bull, 41, pp.3~25 (2008)
18. 하대유, "The Role of Regulatory T Cells in Cancer", Immune Network, 9(6), pp.209~235 (2009), 대한면역학회
19. Beyer M, "Regulatory T cells in cancer", Blood, 108, pp.804~811 (2006)
20. Curiel TJ, "Tregs and rethinking cancer immunotherapy", J Clin Invest, 117, pp.1167~1174 (2007)
21. Curiel TJ, "Regulatory T cells and treatment of cancer", Curr Opin Immunol, 20, pp.241~246 (2008)
22. Fietta AM, "Systemic inflammatory response and downmodulation of peripheral CD25＋Foxp3＋ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer", Hum Immunol, 70, pp.477~486 (2009)
23. Morse MA, "Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines", Blood, 112, pp.610~618 (2008)
24. Liu VC, "Tumor evasion of the immune system by converting CD4＋CD25−T cells into CD4＋CD25＋ T regulatory cells: role of tumor-derived TGF-beta", J Immunol, 178, pp.2883~2892 (2007)
25. Zou W, "Regulatory T cells, tumour immunity and immunotherapy", Nat Rev Immunol, 6, pp.295~307 (2006)
26. Lizée G, "Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms", Clin Cancer Res, 12, pp.4794~4803 (2006)
27. Riley JL, "Human T regulatory cell therapy: take a billion or so and call me in the morning", Immunity, 30, pp.656~665 (2009)
28. Generali D, "Immunomodulation of FOXP3＋ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients", Clin Cancer Res, 15, pp.1046~1051 (2009)
29. Casares N, "A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice", J Immunol, 185, pp.5150~5159 (2010)
30. Xiao Y, "Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function", Curr Opin Immunol, 22, pp.583~591 (2010)
31. Bartel DP, "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
32. Wightman B, "Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans", Cell, 75, pp.855~862 (1993)
33. Lee RC, "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14", Cell, 75, pp.843~854 (1993)
34. Fire A, "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature, 391, pp.806~811 (1998)
35. O’Connell RM, "Physiological and pathological roles for microRNAs in the immune system", Nat Rev Immunol, 10, pp.111~122 (2010)
36. Navarro F, "Small RNAs guide hematopoietic cell differentiation and function", J Immunol, 184, pp.5939~5947 (2010)
37. Slezak-Prochazka I, "MicroRNAs, macrocontrol: regulation of miRNA processing", RNA, 16, pp.1087~1095 (2010)
38. Chen CZ, "MicroRNAs modulate hematopoietic lineage differentiation", Science, 303, pp.83~86 (2004)
39. Kim VN, "Biogenesis of small RNAs in animals", Nat Rev Mol Cell Biol, 10, pp.126~139 (2009)
40. Winter J, "Many roads to maturity: microRNA biogenesis pathways and their regulation", Nat Cell Biol, 11, pp.228~234 (2009)
41. Bartel DP, "MicroRNAs: target recognition and regulatory functions", Cell, 136, pp.215~233 (2009)
42. Schetter AJ, "Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways", Carcinogenesis, 31, pp.37~49 (2010)
43. Miller BH, "MicroRNA dysregulation in psychiatric disease", Brain Res, 1338, pp.89~99 (2010)
44. Pallante P, "Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas", Endocr Relat Cancer, 17, pp.F91~F104 (2010)
45. Haramati S, "miRNA malfunction causes spinal motor neuron disease", Proc Natl Acad Sci U S A, 107, pp.13111~13116 (2010)
46. Radom-Aizik S, "Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes", J Appl Physiol, 109, pp.252~261 (2010)
47. Latronico MV, "MicroRNAs and cardiac pathology", Nat Rev Cardiol, 6, pp.419~429 (2009)
48. Miranda RC, "MicroRNAs: master regulators of ethanol abuse and toxicity", Alcohol Clin Exp Res, 34, pp.575~587 (2010)
49. Wang QZ, "Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy", Curr Cancer Drug Targets, 9, pp.572~594 (2009)
50. Kato M, "MicroRNAs and their role in progressive kidney diseases", Clin J Am Soc Nephrol, 4, pp.1255~1266 (2009)
51. Ohlsson Teague EM, "MicroRNA-regulated pathways associated with endometriosis", Mol Endocrinol, 23, pp.265~275 (2009)
52. Tan Z, "Allele-specific targeting of microRNAs to HLA-G and risk of asthma", Am J Hum Genet, 81, pp.829~834 (2007)
53. Saba R, "A miRNA signature of prion induced neurodegeneration", PLoS One, 3, pp.e3652~ (2008)
54. Pandey AK, "MicroRNAs in diabetes: tiny players in big disease", Cell Physiol Biochem, 23, pp.221~232 (2009)
55. Baltimore D, "MicroRNAs: new regulators of immune cell development and function", Nat Immunol, 9, pp.839~845 (2008)
56. Lodish HF, "Micromanagement of the immune system by microRNAs", Nat Rev Immunol, 8, pp.120~130 (2008)
57. Xiao C, "MicroRNA control in the immune system: basic principles", Cell, 136, pp.26~36 (2009)
58. Lindsay MA, "microRNAs and the immune response", Trends Immunol, 29, pp.343~351 (2008)
59. Rodriguez A, "Requirement of bic", microRNA-155 for normal immune function, 2007, pp.316, 608~611
60. Bird L:, "Regulatory T cells: microRNAs maintain identity", Nat Rev Immunol, 8, pp.752~ (2008)
61. Taganov KD, "MicroRNAs and immunity: tiny players in a big field", Immunity, 26, pp.133~137 (2007)
62. Kosaka N, "microRNA as a new immune-regulatory agent in breast milk", Silence, 1, pp.7~ (2010)
63. Pedersenrene I, "MicroRNAs in the immune response", Cytokine, 43, pp.391~394 (2008)
64. Sonkoly E, "MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation", Semin Cancer Biol, 18, pp.131~140 (2008)
65. Tsitsiou E, "microRNAs and the immune response", Curr Op Pharmacol, 9, pp.514~520 (2009)
66. Liston A, "MicroRNA in the adaptive Immune system, in sickness and in Health", J Clin Immunol, 30, pp.339~346 (2010)
67. Witwer KW, "MicroRNA regulation of IFN-β protein expression: rapid and sensitive modulation of the Innate Immune Response", J Immunology, 184, pp.2369~2376 (2010)
68. Pauley KM, "MicroRNA in autoimmunity and autoimmune diseases", J Autoimmun, 32, pp.189~194 (2009)
69. Liu X, "MiroRNA-148", 152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha, 2010, pp.185, 7244~7251
70. Yang Y, "Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98", let-7, 2011, pp.108, 305~313
71. Hoefig KP, "MicroRNAs grow up in the immune system", Curr Opin Immunol, 20, pp.281~287 (2008)
72. Lynam-Lennon N, "The roles of microRNA in cancer and apoptosis", Biol Rev Camb Philos Soc, 84, pp.55~71 (2009)
73. Zhang B, "microRNAs as oncogenes and tumor suppressors", Dev Biol, 302, pp.1~12 (2007)
74. Hernando E, "microRNAs and cancer: role in tumorigenesis, patient classification and therapy", Clin Transl Oncol, 9, pp.155~160 (2007)
75. Negrini M, "MicroRNAs and cancer-new paradigms in molecular oncology", Curr Opin Cell Biol, 21, pp.470~479 (2009)
76. Ortholan C, "MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets", Curr Med Chem, 16, pp.1047~1061 (2009)
77. Osaki M, "MicroRNAs as biomarkers and therapeutic drugs in human cancer", Biomarkers, 13, pp.658~670 (2008)
78. Lee YS, "MicroRNAs in cancer", Annu Rev Pathol, 4, pp.199~227 (2009)
79. Saito Y, "The role of microRNAs in gastrointestinal cancers", J Gastroenterol, 44(19), pp.18~22 (2009)
80. Guo LM, "MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1", FEBS J, 276, pp.5537~5546 (2009)
81. Weber MJ, "New human and mouse microRNA genes found by homology search", FEBS J, 272, pp.59~73 (2005)
82. Zhang B, "microRNAs: a new emerging class of players for disease diagnostics and gene therapy", J Cell Mol Med, 12, pp.3~21 (2008)
83. Calin GA, "MicroRNA signatures in human cancers", Nat Rev Cancer, 6, pp.857~866 (2006)
84. Chong MM, "The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease", J Exp Med, 205, pp.2005~2017 (2008)
85. Liston A, "Dicer-dependent microRNA pathway safeguards regulatory T cell function", J Exp Med, 205, pp.1993~2004 (2008)
86. Zhou X, "Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity", J Exp Med, 205, pp.1983~1991 (2008)
87. Cobb BS, "A role for Dicer in immune regulation", J Exp Med, 203, pp.2519~2527 (2006)
88. Lu TX, "MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression", J Immunol, 182, pp.4994~5002 (2009)
89. Fulci V, "miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis", Hum Immunol, 71, pp.206~211 (2010)
90. Waldman SA, "A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer", FEBS J, 276, pp.2157~2164 (2009)
91. Waldman SA, "Applications of microRNA in cancer: Exploring the advantages of miRNA", Clin Transl Sci, 2, pp.248~249 (2009)
92. Belver L, "MicroRNAs prevent the generation of autoreactive antibodies", Immunity, 33, pp.713~722 (2010)
93. Yu SL, "MicroRNA signature predicts survival and relapse in lung cancer", Cancer Cell, 13, pp.48~57 (2008)
94. Esau CC, "Therapeutic potential for microRNAs", Adv Drug Deliv Rev, 59, pp.101~114 (2007)
95. Brase JC, "Serum microRNAs as non-invasive biomarkers for cancer", Mol Cancer, 9, pp.306~ (2010)
96. Fazi F, "MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination", Cardiovasc Res, 79, pp.553~561 (2008)
97. Trang P, "MicroRNAs as potential cancer therapeutics", Oncogene, 27(2), pp.S52~S57 (2008)
98. Marson A, "Foxp3 occupancy and regulation of key target genes during T-cell stimulation", Nature, 445, pp.931~935 (2007)
99. Soifer HS, "MicroRNAs in disease and potential therapeutic applications", Mol Ther, 15, pp.2070~2079 (2007)
100. Barringhaus KG, "MicroRNAs: regulating a change of heart", Circulation, 119, pp.2217~2224 (2009)
101. Volinia S, "A microRNA expression signature of human solid tumors defines cancer gene targets", Proc Natl Acad Sci U S A, 103, pp.2257~2261 (2006)
102. Yu Z, "microRNA 17", 20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling, 2010, pp.107, 8231~8236
103. Slaby O, "MicroRNAs in colorectal cancer: translation of molecular biology into clinical application", Mol Cancer, 8, pp.102~ (2009)
104. Croce CM, "Causes and consequences of microRNA dysregulation in cancer", Nat Rev Genet, 10, pp.704~714 (2009)
105. Tili E, "Modulation of miR-155 and miR-125b levels following lipopolysaccharide", TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, 2007, pp.179, 5082~5089
106. Martino S, "MicroRNA implications across neurodevelopment and neuropathology", J Biomed Biotechnol, 2009, pp.654346~ (2009)
107. Luo X, "Evidence for microRNAmediated regulation in rheumatic diseases", Ann Rheum Dis, 69(1), pp.i30~i36 (2010)
108. Tili E, "MicroRNAs, the immune system and rheumatic disease", Nat Clin Pract Rheumatol, 4, pp.534~541 (2008)
109. Sheedy FJ, "Adding fuel to fire: microRNAs as a new class of mediators of inflammation", Ann Rheum Dis, 67(3), pp.iii50~iii55 (2008)
110. Hooper LV, "Immune adaptations that maintain homeostasis with the intestinal microbiota", Nat Rev Immunol, 10, pp.159~169 (2010)
111. Hubert P, "The cross-talk between dendritic and regulatory T cells: good or evil", J Leukoc Biol, 82, pp.781~794 (2007)
112. Toda A, "Development and function of naturally occurring CD4＋CD25＋ regulatory T cells", J Leukoc Biol, 80, pp.458~470 (2006)
113. Wang HY, "Regulatory T cells and cancer", Curr Opin Immunol, 19, pp.217~223 (2007)
114. Han Y, "CD69＋ CD4＋CD25− T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1", J Immunol, 182, pp.111~120 (2009)
115. Maggi E, "Thymic regulatory T cells", Autoimmun Rev, 4, pp.579~586 (2005)
116. Miyara M, "Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor", Immunity, 30, pp.899~911 (2009)
117. Buckner JH, "Mechanisms of impaired regulation by CD4(＋)CD25(＋)FOXP3(＋) regulatory T cells in human autoimmune diseases", Nat Rev Immunol, 10, pp.849~859 (2010)
118. Mabarrack NH, "Recent thymic origin, differentiation, and turnover of regulatory T cells", J Leukoc Biol, 84, pp.1287~1297 (2008)
119. Wan YY, "‘Yin-Yang’ functions of transforming growth factor-beta and T regulatory cells in immune regulation", Immunol Rev, 220, pp.199~213 (2007)
120. Taylor AL, "Superantigen-induced proliferation of human CD4＋CD25− T cells is followed by a switch to a functional regulatory phenotype", J Immunol, 185, pp.6591~6598 (2010)
121. Thornton AM, "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3＋ T regulatory cells", J Immunol, 184, pp.3433~3441 (2010)
122. Curotto de Lafaille MA, "Natural and adaptive foxp3＋ regulatory T cells: more of the same or a division of labor", Immunity, 30, pp.626~635 (2009)
123. Kerdiles YM, "Foxo transcription factors control regulatory T cell development and function", Immunity, 33, pp.890~904 (2010)
124. Procaccini C, "An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness", Immunity, 33, pp.929~941 (2010)
125. Chougnet CA, "A major role for Bim in regulatory T cell homeostasis", J Immunol, 186, pp.156~163 (2011)
126. Stary G, "Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells", J Immunol, 186, pp.103~112 (2011)
127. Eller K, "IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression", J Immunol, 186, pp.83~91 (2011)
128. Baeke F, "The vitamin D analog, TX527, promotes a human CD4＋CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation", J Immunol, 186, pp.132~142 (2011)
129. Fooksman DR, "Functional anatomy of T cell activation and synapse formation", Annu Rev Immunol, 28, pp.79~105 (2010)
130. Chu CY, "Small RNAs: regulators and guardians of the genome", J Cell Physiol, 213, pp.412~419 (2007)
131. V. Narry Kim, "Small RNAs: Classification, Biogenesis, and Function", Molecules and Cells, 19(1), pp.1~15 (2005), 한국분자세포생물학회
132. Dai Y, "Microarray analysis of microRNA expression in peripheral blood cells of systemic erythematosus patients", Lupus, 16, pp.936~946 (2007)
133. Cai X, "Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs", RNA, 10, pp.1957~1966 (2004)
134. 김영국, "The Drosha-DGCR8 complex in primary microRNA processing", GENES & DEVELOPMENT, 18, pp.3016~3027, COLD SPRING HARBOR LAB PRESS
135. Boyd SD, "Everything you wanted to know about small RNA but were afraid to ask", Lab Invest, 88, pp.569~578 (2008)
136. Ketting RF, "Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans", Genes, 15, pp.2654~2659 (2001)
137. Sakaguchi S, "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases", J Immunol, 155, pp.1151~1164 (1995)
138. Schickel R, "MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death", Oncogene, 27, pp.5959~5974 (2008)
139. Bendelac A, "The biology of NKT cells", Annu Rev Immunol, 25, pp.297~336 (2007)
140. Pauley KM, "MicroRNAs and their emerging roles in immunology", Ann N Y Acad Sci, 1143, pp.226~239 (2008)
141. Moschos SA, "Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids", BMC Genomics, 8, pp.240~ (2007)
142. Li Y, "MicroRNA expression and virulence in pandemic influenza virus-infected mice", J Virol, 84, pp.3023~3032 (2010)
143. De Santis G, "Altered miRNA expression in T regulatory cells in course of multiple sclerosis", J Neuroimmunol, 226, pp.165~171 (2010)
144. Fichtlscherer S, "Circulating microRNAs in patients with coronary artery disease", Circ Res, 107, pp.677~684 (2010)
145. Ji X, "Plasma miR-208 as a biomarker of myocardial injury", Clin Chem, 55, pp.1944~1949 (2009)
146. Mitchell PS, "Circulating microRNAs as stable blood-based markers for cancer detection", Proc Natl Acad Sci U S A, 105, pp.10513~10518 (2008)
147. Michael A, "Exosome from human saliva as a source of microRNA biomarkers", Oral Dis, 16, pp.34~38 (2010)
148. Chen X, "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases", Cell Res, 18, pp.997~1006 (2008)
149. O’Connell RM, "MicroRNA-155 is induced during the macrophage inflammatory response", Proc Natl Acad Sci U S A, 104, pp.1604~1609 (2007)
150. Vigorito E, "microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells", Immunity, 27, pp.847~859 (2007)
151. Lu LF, "Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein", Immunity, 30, pp.80~91 (2009)
152. Zhu QY, "MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages", J Immunol, 185, pp.7435~7442 (2010)
153. Taganov KD, "NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses", Proc Natl Acad Sci U S A, 103, pp.12481~12486 (2006)
154. Hou J, "MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2", J Immunol, 183, pp.2150~2158 (2009)
155. Androulidaki A, "The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs", Immunity, 31, pp.220~231 (2009)
156. Fazi F, "A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C", EBPalpha regulates human granulopoiesis, 2005, pp.123, 819~831
157. Johnnidis JB, "Regulation of progenitor cell proliferation and granulocyte function by microRNA-223", Nature, 451, pp.1125~1129 (2008)
158. Li QJ, "miR-181a is an intrinsic modulator of T cell sensitivity and selection", Cell, 129, pp.147~161 (2007)
159. Lapaque N, "Interactions between human NK cells and macrophages in response to Salmonella infection", J Immunol, 182, pp.4339~4348 (2009)
160. Stern-Ginossar N, "Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D", Nat Immunol, 9, pp.1065~1073 (2008)
161. Bezman NA, "Distinct requirements of microRNAs in NK cell activation, survival, and function", J Immunol, 185, pp.3835~3846 (2010)
162. Koralov SB, "Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage", Cell, 132, pp.860~874 (2008)
163. Cobb BS, "T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer", J Exp Med, 201, pp.1367~1373 (2005)
164. Muljo SA, "Aberrant T cell differentiation in the absence of Dicer", J Exp Med, 202, pp.261~269 (2005)
165. Fedeli M, "Dicer-dependent microRNA pathway controls invariant NKT cell development", J Immunol, 183, pp.2506~2512 (2009)
166. Rossi M, "Human dendritic cells: potent antigen- presenting cells at the crossroads of innate and adaptive immunity", J Immunol, 175, pp.1373~1381 (2005)
167. Ceppi M, "MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells", Proc Natl Acad Sci U S A, 106, pp.2735~2740 (2009)
168. Holmstrøm K, "Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy", Hum Immunol, 71, pp.67~73 (2010)
169. Curtale G, "An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes", Blood, 115, pp.265~273 (2010)
170. Basso K, "Identification of the human mature B cell miRNome", Immunity, 30, pp.744~752 (2009)
171. Eis PS, "Accumulation of miR-155 and BIC RNA in human B cell lymphomas", Proc Natl Acad Sci U S A, 102, pp.3627~3632 (2005)
172. Kluiver J, "BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas", J Pathol, 207, pp.243~249 (2005)
173. Kluiver J, "Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma", Genes Chromosomes Cancer, 45, pp.147~153 (2006)
174. Turner M, "Regulation of B- and T-cell differentiation by a single microRNA", Biochem Soc Trans, 36, pp.531~533 (2008)
175. Costinean S, "Pre-B cell proliferation and lymphoblastic leukemia", high-grade lymphoma in E(mu)- miR155 transgenic mice, 2006, pp.103, 7024~7029
176. Thai TH, "Regulation of the germinal center response by microRNA-155", Science, 316, pp.604~608 (2007)
177. Xiao C, "MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb", Cell, 131, pp.146~159 (2007)
178. Zhou B, "miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely", Proc Natl Acad Sci U S A, 104, pp.7080~7085 (2007)
179. Dorsett Y, "MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation", Immunity, 28, pp.630~638 (2008)
180. Zhang J, "Patterns of microRNA expression characterize stages of human B-cell differentiation", Blood, 113, pp.4586~4594 (2009)
181. Lee PP, "A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival", Immunity, 15, pp.763~774 (2001)
182. Banerjee A, "Micro-RNA-155 inhibits IFN-gamma signaling in CD4＋ T cells", Eur J Immunol, 40, pp.225~231 (2010)
183. Neilson JR, "Dynamic regulation of miRNA expression in ordered stages of cellular development", Genes Dev, 21, pp.578~589 (2007)
184. Johnston RJ, "Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation", Science, 325, pp.1006~1010 (2009)
185. Tufekci KU, "MicroRNAs and Multiple Sclerosis", Autoimmune Dis, 2011, pp.807426~ (2010)
186. Divekar AA, "Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu", J Immunol, 186, pp.924~930 (2011)
187. Zheng Y, "Gavin MA, Rudensky AY: Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells", Nature, 445, pp.936~940 (2007)
188. Zhou L, "MicroRNAs and immune regulatory T cells", Int Immunopharmacol, 9, pp.524~527 (2009)
189. Kohlhaas S, "Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells", J Immunol, 182, pp.2578~2582 (2009)
190. Redouane R, "Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXP3 expression", Eur J Immunol, 39, pp.1~11 (2009)
191. Huang B, "miR-142-3p restricts cAMP production in CD4＋CD25− T cells and CD4＋CD25＋ TREG cells by targeting AC9 mRNA", EMBO Rep, 10, pp.180~185 (2009)
192. Fayyad-Kazan H, "Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase", J Biol Chem, 285, pp.20481~20491 (2010)
193. Rouas R, "Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression", Eur J Immunol, 39, pp.1608~1618 (2009)
194. Hezova R, "microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients", Cell Immunol, 260, pp.70~74 (2010)
195. Freier E, "Decrease of CD4(＋)FOXP3(＋) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor", Psychoneuroendocrinology, 35, pp.663~673 (2010)
196. Lu LF, "Molecular orchestration of differentiation and function of regulatory T cells", Genes Dev, 23, pp.1270~1282 (2009)
197. Lu LF, "Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses", Cell, 142, pp.914~929 (2010)
198. Bopp T, "Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression", J Exp Med, 204, pp.1303~1310 (2007)
199. Asirvatham AJ, "MicroRNA targets in immune genes and the Dicer", Argonaute and ARE machinery components, 2008, pp.45, 1995~2006
200. Kota J, "Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model", Cell, 137, pp.1005~1017 (2009)
201. Calin GA, "A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia", N Engl J Med, 353, pp.1793~1801 (2005)
202. Schetter AJ, "MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma", JAMA, 299, pp.425~436 (2008)
203. Waldman SA, "MicroRNA signatures as diagnostic and therapeutic targets", Clin Chem, 54, pp.943~944 (2008)
204. Inomata M, "MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes", Blood, 113, pp.396~402 (2009)
205. Packer AN, "The bifunctional microRNA miR-9", miR-9* regulates REST and CoREST and is downregulated in Huntington's disease, 2008, pp.28, 14341~14346
206. Bullrich F, "Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene", Cancer Res, 61, pp.6640~6648 (2001)
207. Garzon R, "MicroRNA 29b functions in acute myeloid leukemia", Blood, 114, pp.5331~5341 (2009)
208. Tavazoie SF, "Endogenous human microRNAs that suppress breast cancer metastasis", Nature, 451, pp.147~152 (2008)
209. Corsten MF, "Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease", Circ Cardiovasc Genet, 3, pp.499~506 (2010)
210. Wang K, "Circulating microRNAs, potential biomarkers for drug-induced liver injury", Proc Natl Acad Sci U S A, 106, pp.4402~4407 (2009)
211. Schaefer A, "Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma", Int J Cancer, 126, pp.1166~1176 (2010)
212. Heneghan HM, "MiRNAs as biomarkers and therapeutic targets in cancer", Curr Opin Pharmacol, 10, pp.543~550 (2010)
213. De Smaele E, "MicroRNAs as biomarkers for CNS cancer and other disorders", Brain Res, 1338, pp.100~111 (2010)
214. Zhi F, "The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma", Eur J Cancer, 46, pp.1640~1649 (2010)

관련 논문AI추천